nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—SLCO1B3—Methotrexate—psoriatic arthritis	0.145	0.192	CbGbCtD
Atazanavir—ABCC1—Methotrexate—psoriatic arthritis	0.1	0.133	CbGbCtD
Atazanavir—ABCB1—Methylprednisolone—psoriatic arthritis	0.0794	0.106	CbGbCtD
Atazanavir—ABCB1—Betamethasone—psoriatic arthritis	0.0516	0.0687	CbGbCtD
Atazanavir—ABCB1—Prednisolone—psoriatic arthritis	0.051	0.0678	CbGbCtD
Atazanavir—ABCB1—Prednisone—psoriatic arthritis	0.0481	0.064	CbGbCtD
Atazanavir—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0476	0.0633	CbGbCtD
Atazanavir—CYP3A4—Triamcinolone—psoriatic arthritis	0.0361	0.048	CbGbCtD
Atazanavir—CYP2C9—Dexamethasone—psoriatic arthritis	0.031	0.0412	CbGbCtD
Atazanavir—CYP3A4—Betamethasone—psoriatic arthritis	0.0309	0.0411	CbGbCtD
Atazanavir—CYP3A4—Prednisolone—psoriatic arthritis	0.0305	0.0406	CbGbCtD
Atazanavir—ABCB1—Dexamethasone—psoriatic arthritis	0.03	0.0399	CbGbCtD
Atazanavir—CYP3A4—Prednisone—psoriatic arthritis	0.0288	0.0383	CbGbCtD
Atazanavir—ABCB1—Methotrexate—psoriatic arthritis	0.0241	0.0321	CbGbCtD
Atazanavir—CYP3A4—Dexamethasone—psoriatic arthritis	0.018	0.0239	CbGbCtD
Atazanavir—Convulsion—Methylprednisolone—psoriatic arthritis	0.000287	0.00116	CcSEcCtD
Atazanavir—Hypertension—Triamcinolone—psoriatic arthritis	0.000286	0.00115	CcSEcCtD
Atazanavir—Hypertension—Methylprednisolone—psoriatic arthritis	0.000286	0.00115	CcSEcCtD
Atazanavir—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000284	0.00115	CcSEcCtD
Atazanavir—Myalgia—Triamcinolone—psoriatic arthritis	0.000282	0.00114	CcSEcCtD
Atazanavir—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000282	0.00114	CcSEcCtD
Atazanavir—Myalgia—Methylprednisolone—psoriatic arthritis	0.000282	0.00114	CcSEcCtD
Atazanavir—Eye disorder—Prednisone—psoriatic arthritis	0.000281	0.00113	CcSEcCtD
Atazanavir—Anxiety—Methylprednisolone—psoriatic arthritis	0.000281	0.00113	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00028	0.00113	CcSEcCtD
Atazanavir—Depression—Methotrexate—psoriatic arthritis	0.000279	0.00113	CcSEcCtD
Atazanavir—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000279	0.00113	CcSEcCtD
Atazanavir—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000279	0.00113	CcSEcCtD
Atazanavir—Discomfort—Triamcinolone—psoriatic arthritis	0.000279	0.00112	CcSEcCtD
Atazanavir—Discomfort—Methylprednisolone—psoriatic arthritis	0.000278	0.00112	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.000278	0.00112	CcSEcCtD
Atazanavir—Dry mouth—Triamcinolone—psoriatic arthritis	0.000276	0.00111	CcSEcCtD
Atazanavir—Renal failure—Methotrexate—psoriatic arthritis	0.000275	0.00111	CcSEcCtD
Atazanavir—Angioedema—Dexamethasone—psoriatic arthritis	0.000275	0.00111	CcSEcCtD
Atazanavir—Angioedema—Betamethasone—psoriatic arthritis	0.000275	0.00111	CcSEcCtD
Atazanavir—Stomatitis—Methotrexate—psoriatic arthritis	0.000273	0.0011	CcSEcCtD
Atazanavir—Angiopathy—Prednisone—psoriatic arthritis	0.000273	0.0011	CcSEcCtD
Atazanavir—Confusional state—Methylprednisolone—psoriatic arthritis	0.000272	0.0011	CcSEcCtD
Atazanavir—Immune system disorder—Prednisone—psoriatic arthritis	0.000272	0.0011	CcSEcCtD
Atazanavir—Malaise—Betamethasone—psoriatic arthritis	0.000271	0.00109	CcSEcCtD
Atazanavir—Malaise—Dexamethasone—psoriatic arthritis	0.000271	0.00109	CcSEcCtD
Atazanavir—Oedema—Triamcinolone—psoriatic arthritis	0.000271	0.00109	CcSEcCtD
Atazanavir—Syncope—Dexamethasone—psoriatic arthritis	0.00027	0.00109	CcSEcCtD
Atazanavir—Syncope—Betamethasone—psoriatic arthritis	0.00027	0.00109	CcSEcCtD
Atazanavir—Infection—Triamcinolone—psoriatic arthritis	0.000269	0.00108	CcSEcCtD
Atazanavir—Sweating—Methotrexate—psoriatic arthritis	0.000269	0.00108	CcSEcCtD
Atazanavir—Infection—Methylprednisolone—psoriatic arthritis	0.000268	0.00108	CcSEcCtD
Atazanavir—Haematuria—Methotrexate—psoriatic arthritis	0.000267	0.00108	CcSEcCtD
Atazanavir—Shock—Triamcinolone—psoriatic arthritis	0.000266	0.00107	CcSEcCtD
Atazanavir—Insomnia—Prednisolone—psoriatic arthritis	0.000266	0.00107	CcSEcCtD
Atazanavir—Alopecia—Prednisone—psoriatic arthritis	0.000266	0.00107	CcSEcCtD
Atazanavir—Shock—Methylprednisolone—psoriatic arthritis	0.000266	0.00107	CcSEcCtD
Atazanavir—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000265	0.00107	CcSEcCtD
Atazanavir—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000265	0.00107	CcSEcCtD
Atazanavir—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000264	0.00107	CcSEcCtD
Atazanavir—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000264	0.00107	CcSEcCtD
Atazanavir—Mental disorder—Prednisone—psoriatic arthritis	0.000264	0.00106	CcSEcCtD
Atazanavir—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000262	0.00106	CcSEcCtD
Atazanavir—Malnutrition—Prednisone—psoriatic arthritis	0.000262	0.00106	CcSEcCtD
Atazanavir—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000262	0.00106	CcSEcCtD
Atazanavir—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000261	0.00105	CcSEcCtD
Atazanavir—Convulsion—Betamethasone—psoriatic arthritis	0.000261	0.00105	CcSEcCtD
Atazanavir—Convulsion—Dexamethasone—psoriatic arthritis	0.000261	0.00105	CcSEcCtD
Atazanavir—Hypertension—Dexamethasone—psoriatic arthritis	0.00026	0.00105	CcSEcCtD
Atazanavir—Hypertension—Betamethasone—psoriatic arthritis	0.00026	0.00105	CcSEcCtD
Atazanavir—Myalgia—Betamethasone—psoriatic arthritis	0.000256	0.00103	CcSEcCtD
Atazanavir—Myalgia—Dexamethasone—psoriatic arthritis	0.000256	0.00103	CcSEcCtD
Atazanavir—Anxiety—Dexamethasone—psoriatic arthritis	0.000255	0.00103	CcSEcCtD
Atazanavir—Anxiety—Betamethasone—psoriatic arthritis	0.000255	0.00103	CcSEcCtD
Atazanavir—Discomfort—Dexamethasone—psoriatic arthritis	0.000253	0.00102	CcSEcCtD
Atazanavir—Discomfort—Betamethasone—psoriatic arthritis	0.000253	0.00102	CcSEcCtD
Atazanavir—Pain—Prednisolone—psoriatic arthritis	0.000252	0.00101	CcSEcCtD
Atazanavir—Hepatitis—Methotrexate—psoriatic arthritis	0.000252	0.00101	CcSEcCtD
Atazanavir—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000248	0.001	CcSEcCtD
Atazanavir—Urethral disorder—Methotrexate—psoriatic arthritis	0.000247	0.000994	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000247	0.000994	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000246	0.000992	CcSEcCtD
Atazanavir—Oedema—Dexamethasone—psoriatic arthritis	0.000246	0.00099	CcSEcCtD
Atazanavir—Oedema—Betamethasone—psoriatic arthritis	0.000246	0.00099	CcSEcCtD
Atazanavir—Insomnia—Triamcinolone—psoriatic arthritis	0.000245	0.000987	CcSEcCtD
Atazanavir—Insomnia—Methylprednisolone—psoriatic arthritis	0.000244	0.000985	CcSEcCtD
Atazanavir—Infection—Dexamethasone—psoriatic arthritis	0.000244	0.000984	CcSEcCtD
Atazanavir—Infection—Betamethasone—psoriatic arthritis	0.000244	0.000984	CcSEcCtD
Atazanavir—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000243	0.00098	CcSEcCtD
Atazanavir—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000242	0.000978	CcSEcCtD
Atazanavir—Shock—Betamethasone—psoriatic arthritis	0.000242	0.000974	CcSEcCtD
Atazanavir—Shock—Dexamethasone—psoriatic arthritis	0.000242	0.000974	CcSEcCtD
Atazanavir—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000241	0.000973	CcSEcCtD
Atazanavir—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000241	0.000971	CcSEcCtD
Atazanavir—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000241	0.000971	CcSEcCtD
Atazanavir—Agitation—Prednisone—psoriatic arthritis	0.000241	0.000971	CcSEcCtD
Atazanavir—Angioedema—Prednisone—psoriatic arthritis	0.000239	0.000965	CcSEcCtD
Atazanavir—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000238	0.000961	CcSEcCtD
Atazanavir—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000238	0.000959	CcSEcCtD
Atazanavir—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000238	0.000958	CcSEcCtD
Atazanavir—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000237	0.000957	CcSEcCtD
Atazanavir—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000237	0.000957	CcSEcCtD
Atazanavir—Malaise—Prednisone—psoriatic arthritis	0.000236	0.000953	CcSEcCtD
Atazanavir—Eye disorder—Methotrexate—psoriatic arthritis	0.000235	0.000948	CcSEcCtD
Atazanavir—Syncope—Prednisone—psoriatic arthritis	0.000235	0.000948	CcSEcCtD
Atazanavir—Tinnitus—Methotrexate—psoriatic arthritis	0.000235	0.000946	CcSEcCtD
Atazanavir—Anorexia—Dexamethasone—psoriatic arthritis	0.000234	0.000944	CcSEcCtD
Atazanavir—Anorexia—Betamethasone—psoriatic arthritis	0.000234	0.000944	CcSEcCtD
Atazanavir—Urticaria—Prednisolone—psoriatic arthritis	0.000234	0.000943	CcSEcCtD
Atazanavir—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000233	0.000941	CcSEcCtD
Atazanavir—Fatigue—Triamcinolone—psoriatic arthritis	0.000233	0.000941	CcSEcCtD
Atazanavir—Fatigue—Methylprednisolone—psoriatic arthritis	0.000233	0.000939	CcSEcCtD
Atazanavir—Pain—Triamcinolone—psoriatic arthritis	0.000231	0.000933	CcSEcCtD
Atazanavir—Loss of consciousness—Prednisone—psoriatic arthritis	0.00023	0.000929	CcSEcCtD
Atazanavir—Angiopathy—Methotrexate—psoriatic arthritis	0.000228	0.00092	CcSEcCtD
Atazanavir—Immune system disorder—Methotrexate—psoriatic arthritis	0.000227	0.000916	CcSEcCtD
Atazanavir—Convulsion—Prednisone—psoriatic arthritis	0.000227	0.000915	CcSEcCtD
Atazanavir—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000227	0.000914	CcSEcCtD
Atazanavir—Hypertension—Prednisone—psoriatic arthritis	0.000226	0.000912	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000224	0.000902	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000224	0.000902	CcSEcCtD
Atazanavir—Arthralgia—Prednisone—psoriatic arthritis	0.000223	0.0009	CcSEcCtD
Atazanavir—Myalgia—Prednisone—psoriatic arthritis	0.000223	0.0009	CcSEcCtD
Atazanavir—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000223	0.000899	CcSEcCtD
Atazanavir—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000223	0.000897	CcSEcCtD
Atazanavir—Anxiety—Prednisone—psoriatic arthritis	0.000222	0.000896	CcSEcCtD
Atazanavir—Alopecia—Methotrexate—psoriatic arthritis	0.000222	0.000896	CcSEcCtD
Atazanavir—Insomnia—Dexamethasone—psoriatic arthritis	0.000222	0.000896	CcSEcCtD
Atazanavir—Insomnia—Betamethasone—psoriatic arthritis	0.000222	0.000896	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000222	0.000893	CcSEcCtD
Atazanavir—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000221	0.00089	CcSEcCtD
Atazanavir—Discomfort—Prednisone—psoriatic arthritis	0.00022	0.000889	CcSEcCtD
Atazanavir—Mental disorder—Methotrexate—psoriatic arthritis	0.00022	0.000889	CcSEcCtD
Atazanavir—Malnutrition—Methotrexate—psoriatic arthritis	0.000219	0.000883	CcSEcCtD
Atazanavir—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000217	0.000874	CcSEcCtD
Atazanavir—Dyspepsia—Betamethasone—psoriatic arthritis	0.000216	0.000872	CcSEcCtD
Atazanavir—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000216	0.000872	CcSEcCtD
Atazanavir—Urticaria—Triamcinolone—psoriatic arthritis	0.000215	0.000867	CcSEcCtD
Atazanavir—Urticaria—Methylprednisolone—psoriatic arthritis	0.000215	0.000865	CcSEcCtD
Atazanavir—Dysgeusia—Methotrexate—psoriatic arthritis	0.000214	0.000865	CcSEcCtD
Atazanavir—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000214	0.000863	CcSEcCtD
Atazanavir—Oedema—Prednisone—psoriatic arthritis	0.000214	0.000862	CcSEcCtD
Atazanavir—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000213	0.000861	CcSEcCtD
Atazanavir—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000213	0.000861	CcSEcCtD
Atazanavir—Decreased appetite—Betamethasone—psoriatic arthritis	0.000213	0.000861	CcSEcCtD
Atazanavir—Infection—Prednisone—psoriatic arthritis	0.000212	0.000857	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000212	0.000855	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000212	0.000855	CcSEcCtD
Atazanavir—Back pain—Methotrexate—psoriatic arthritis	0.000212	0.000854	CcSEcCtD
Atazanavir—Fatigue—Dexamethasone—psoriatic arthritis	0.000212	0.000854	CcSEcCtD
Atazanavir—Fatigue—Betamethasone—psoriatic arthritis	0.000212	0.000854	CcSEcCtD
Atazanavir—Shock—Prednisone—psoriatic arthritis	0.00021	0.000848	CcSEcCtD
Atazanavir—Pain—Betamethasone—psoriatic arthritis	0.00021	0.000847	CcSEcCtD
Atazanavir—Pain—Dexamethasone—psoriatic arthritis	0.00021	0.000847	CcSEcCtD
Atazanavir—Nervous system disorder—Prednisone—psoriatic arthritis	0.00021	0.000846	CcSEcCtD
Atazanavir—Skin disorder—Prednisone—psoriatic arthritis	0.000208	0.000838	CcSEcCtD
Atazanavir—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000207	0.000834	CcSEcCtD
Atazanavir—Anorexia—Prednisone—psoriatic arthritis	0.000204	0.000822	CcSEcCtD
Atazanavir—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000203	0.000819	CcSEcCtD
Atazanavir—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000202	0.000816	CcSEcCtD
Atazanavir—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000202	0.000816	CcSEcCtD
Atazanavir—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000201	0.00081	CcSEcCtD
Atazanavir—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000201	0.00081	CcSEcCtD
Atazanavir—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000199	0.000804	CcSEcCtD
Atazanavir—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000199	0.000802	CcSEcCtD
Atazanavir—Malaise—Methotrexate—psoriatic arthritis	0.000197	0.000796	CcSEcCtD
Atazanavir—Urticaria—Betamethasone—psoriatic arthritis	0.000195	0.000787	CcSEcCtD
Atazanavir—Urticaria—Dexamethasone—psoriatic arthritis	0.000195	0.000787	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000195	0.000786	CcSEcCtD
Atazanavir—Dizziness—Prednisolone—psoriatic arthritis	0.000195	0.000785	CcSEcCtD
Atazanavir—Asthenia—Triamcinolone—psoriatic arthritis	0.000194	0.000783	CcSEcCtD
Atazanavir—Abdominal pain—Betamethasone—psoriatic arthritis	0.000194	0.000783	CcSEcCtD
Atazanavir—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000194	0.000783	CcSEcCtD
Atazanavir—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000194	0.000783	CcSEcCtD
Atazanavir—Body temperature increased—Betamethasone—psoriatic arthritis	0.000194	0.000783	CcSEcCtD
Atazanavir—Asthenia—Methylprednisolone—psoriatic arthritis	0.000194	0.000781	CcSEcCtD
Atazanavir—Insomnia—Prednisone—psoriatic arthritis	0.000193	0.00078	CcSEcCtD
Atazanavir—Pruritus—Triamcinolone—psoriatic arthritis	0.000191	0.000772	CcSEcCtD
Atazanavir—Cough—Methotrexate—psoriatic arthritis	0.000191	0.000771	CcSEcCtD
Atazanavir—Pruritus—Methylprednisolone—psoriatic arthritis	0.000191	0.00077	CcSEcCtD
Atazanavir—Convulsion—Methotrexate—psoriatic arthritis	0.00019	0.000765	CcSEcCtD
Atazanavir—Dyspepsia—Prednisone—psoriatic arthritis	0.000188	0.000759	CcSEcCtD
Atazanavir—Myalgia—Methotrexate—psoriatic arthritis	0.000186	0.000752	CcSEcCtD
Atazanavir—Chest pain—Methotrexate—psoriatic arthritis	0.000186	0.000752	CcSEcCtD
Atazanavir—Arthralgia—Methotrexate—psoriatic arthritis	0.000186	0.000752	CcSEcCtD
Atazanavir—Decreased appetite—Prednisone—psoriatic arthritis	0.000186	0.00075	CcSEcCtD
Atazanavir—Rash—Prednisolone—psoriatic arthritis	0.000186	0.000748	CcSEcCtD
Atazanavir—Dermatitis—Prednisolone—psoriatic arthritis	0.000185	0.000748	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000185	0.000747	CcSEcCtD
Atazanavir—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000185	0.000745	CcSEcCtD
Atazanavir—Fatigue—Prednisone—psoriatic arthritis	0.000184	0.000743	CcSEcCtD
Atazanavir—Headache—Prednisolone—psoriatic arthritis	0.000184	0.000743	CcSEcCtD
Atazanavir—Discomfort—Methotrexate—psoriatic arthritis	0.000184	0.000743	CcSEcCtD
Atazanavir—Constipation—Prednisone—psoriatic arthritis	0.000183	0.000737	CcSEcCtD
Atazanavir—Confusional state—Methotrexate—psoriatic arthritis	0.00018	0.000727	CcSEcCtD
Atazanavir—Dizziness—Triamcinolone—psoriatic arthritis	0.000179	0.000722	CcSEcCtD
Atazanavir—Dizziness—Methylprednisolone—psoriatic arthritis	0.000179	0.00072	CcSEcCtD
Atazanavir—Infection—Methotrexate—psoriatic arthritis	0.000178	0.000716	CcSEcCtD
Atazanavir—Feeling abnormal—Prednisone—psoriatic arthritis	0.000176	0.000711	CcSEcCtD
Atazanavir—Asthenia—Betamethasone—psoriatic arthritis	0.000176	0.00071	CcSEcCtD
Atazanavir—Asthenia—Dexamethasone—psoriatic arthritis	0.000176	0.00071	CcSEcCtD
Atazanavir—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000175	0.000707	CcSEcCtD
Atazanavir—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000175	0.000705	CcSEcCtD
Atazanavir—Nausea—Prednisolone—psoriatic arthritis	0.000175	0.000705	CcSEcCtD
Atazanavir—Pruritus—Dexamethasone—psoriatic arthritis	0.000174	0.000701	CcSEcCtD
Atazanavir—Pruritus—Betamethasone—psoriatic arthritis	0.000174	0.000701	CcSEcCtD
Atazanavir—Skin disorder—Methotrexate—psoriatic arthritis	0.000174	0.0007	CcSEcCtD
Atazanavir—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000173	0.000697	CcSEcCtD
Atazanavir—Vomiting—Triamcinolone—psoriatic arthritis	0.000172	0.000694	CcSEcCtD
Atazanavir—Vomiting—Methylprednisolone—psoriatic arthritis	0.000172	0.000692	CcSEcCtD
Atazanavir—Rash—Triamcinolone—psoriatic arthritis	0.000171	0.000688	CcSEcCtD
Atazanavir—Dermatitis—Triamcinolone—psoriatic arthritis	0.00017	0.000687	CcSEcCtD
Atazanavir—Anorexia—Methotrexate—psoriatic arthritis	0.00017	0.000687	CcSEcCtD
Atazanavir—Rash—Methylprednisolone—psoriatic arthritis	0.00017	0.000687	CcSEcCtD
Atazanavir—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00017	0.000686	CcSEcCtD
Atazanavir—Urticaria—Prednisone—psoriatic arthritis	0.00017	0.000685	CcSEcCtD
Atazanavir—Headache—Triamcinolone—psoriatic arthritis	0.00017	0.000684	CcSEcCtD
Atazanavir—Headache—Methylprednisolone—psoriatic arthritis	0.000169	0.000682	CcSEcCtD
Atazanavir—Abdominal pain—Prednisone—psoriatic arthritis	0.000169	0.000682	CcSEcCtD
Atazanavir—Body temperature increased—Prednisone—psoriatic arthritis	0.000169	0.000682	CcSEcCtD
Atazanavir—Diarrhoea—Betamethasone—psoriatic arthritis	0.000168	0.000678	CcSEcCtD
Atazanavir—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000168	0.000678	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000163	0.000657	CcSEcCtD
Atazanavir—Dizziness—Betamethasone—psoriatic arthritis	0.000162	0.000655	CcSEcCtD
Atazanavir—Dizziness—Dexamethasone—psoriatic arthritis	0.000162	0.000655	CcSEcCtD
Atazanavir—Insomnia—Methotrexate—psoriatic arthritis	0.000162	0.000652	CcSEcCtD
Atazanavir—Nausea—Triamcinolone—psoriatic arthritis	0.000161	0.000648	CcSEcCtD
Atazanavir—Nausea—Methylprednisolone—psoriatic arthritis	0.00016	0.000647	CcSEcCtD
Atazanavir—Dyspnoea—Methotrexate—psoriatic arthritis	0.000159	0.000643	CcSEcCtD
Atazanavir—Somnolence—Methotrexate—psoriatic arthritis	0.000159	0.000641	CcSEcCtD
Atazanavir—Hypersensitivity—Prednisone—psoriatic arthritis	0.000158	0.000635	CcSEcCtD
Atazanavir—Dyspepsia—Methotrexate—psoriatic arthritis	0.000157	0.000634	CcSEcCtD
Atazanavir—Vomiting—Betamethasone—psoriatic arthritis	0.000156	0.00063	CcSEcCtD
Atazanavir—Vomiting—Dexamethasone—psoriatic arthritis	0.000156	0.00063	CcSEcCtD
Atazanavir—Decreased appetite—Methotrexate—psoriatic arthritis	0.000155	0.000626	CcSEcCtD
Atazanavir—Rash—Dexamethasone—psoriatic arthritis	0.000155	0.000624	CcSEcCtD
Atazanavir—Rash—Betamethasone—psoriatic arthritis	0.000155	0.000624	CcSEcCtD
Atazanavir—Dermatitis—Dexamethasone—psoriatic arthritis	0.000155	0.000624	CcSEcCtD
Atazanavir—Dermatitis—Betamethasone—psoriatic arthritis	0.000155	0.000624	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000154	0.000622	CcSEcCtD
Atazanavir—Fatigue—Methotrexate—psoriatic arthritis	0.000154	0.000621	CcSEcCtD
Atazanavir—Headache—Dexamethasone—psoriatic arthritis	0.000154	0.00062	CcSEcCtD
Atazanavir—Headache—Betamethasone—psoriatic arthritis	0.000154	0.00062	CcSEcCtD
Atazanavir—Asthenia—Prednisone—psoriatic arthritis	0.000153	0.000619	CcSEcCtD
Atazanavir—Pain—Methotrexate—psoriatic arthritis	0.000153	0.000616	CcSEcCtD
Atazanavir—Pruritus—Prednisone—psoriatic arthritis	0.000151	0.00061	CcSEcCtD
Atazanavir—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000147	0.000594	CcSEcCtD
Atazanavir—Diarrhoea—Prednisone—psoriatic arthritis	0.000146	0.00059	CcSEcCtD
Atazanavir—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000146	0.000589	CcSEcCtD
Atazanavir—Nausea—Dexamethasone—psoriatic arthritis	0.000146	0.000588	CcSEcCtD
Atazanavir—Nausea—Betamethasone—psoriatic arthritis	0.000146	0.000588	CcSEcCtD
Atazanavir—Urticaria—Methotrexate—psoriatic arthritis	0.000142	0.000573	CcSEcCtD
Atazanavir—Dizziness—Prednisone—psoriatic arthritis	0.000141	0.00057	CcSEcCtD
Atazanavir—Body temperature increased—Methotrexate—psoriatic arthritis	0.000141	0.00057	CcSEcCtD
Atazanavir—Abdominal pain—Methotrexate—psoriatic arthritis	0.000141	0.00057	CcSEcCtD
Atazanavir—Vomiting—Prednisone—psoriatic arthritis	0.000136	0.000548	CcSEcCtD
Atazanavir—Rash—Prednisone—psoriatic arthritis	0.000135	0.000544	CcSEcCtD
Atazanavir—Dermatitis—Prednisone—psoriatic arthritis	0.000135	0.000543	CcSEcCtD
Atazanavir—Headache—Prednisone—psoriatic arthritis	0.000134	0.00054	CcSEcCtD
Atazanavir—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000132	0.000531	CcSEcCtD
Atazanavir—Asthenia—Methotrexate—psoriatic arthritis	0.000128	0.000517	CcSEcCtD
Atazanavir—Nausea—Prednisone—psoriatic arthritis	0.000127	0.000512	CcSEcCtD
Atazanavir—Pruritus—Methotrexate—psoriatic arthritis	0.000126	0.00051	CcSEcCtD
Atazanavir—Diarrhoea—Methotrexate—psoriatic arthritis	0.000122	0.000493	CcSEcCtD
Atazanavir—Dizziness—Methotrexate—psoriatic arthritis	0.000118	0.000477	CcSEcCtD
Atazanavir—Vomiting—Methotrexate—psoriatic arthritis	0.000114	0.000458	CcSEcCtD
Atazanavir—Rash—Methotrexate—psoriatic arthritis	0.000113	0.000454	CcSEcCtD
Atazanavir—Dermatitis—Methotrexate—psoriatic arthritis	0.000113	0.000454	CcSEcCtD
Atazanavir—Headache—Methotrexate—psoriatic arthritis	0.000112	0.000451	CcSEcCtD
Atazanavir—Nausea—Methotrexate—psoriatic arthritis	0.000106	0.000428	CcSEcCtD
